Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Companies

Ex-Novartis Diagnostics President Assumes New Roles

This article was originally published in Scrip

Executive Summary

Gene Walther, who was previously Novartis' diagnostics president, has been appointed head of NetScientific Plc.'s diagnostics franchise and will become the CEO of the company's portfolio company, Vortex BioSciences – effective Jan. 4, 2016. Walther replaces Vortex BioSciences' interim CEO, Michael Boyce-Jacino, who will leave the company and board of directors at the end of December 2015. Most recently Walther was consultant to the Paul G. Allen Family Foundation. Prior to this he was deputy director, diagnostics for the Bill & Melinda Gates Foundation and he also served as executive chair of GenturaDx's board. Walther spent over a decade at Novartis as president and global head of diagnostics.

Table

View full table

Topics

Tags:
Companies
Latest Headlines

The UK’s Cancer Vaccine Partnership With BioNTech Is Another First – But Can It Deliver?

NASDAQ Is Nice But Home Provides Comfort For Europe’s Biotechs

Amgen Planning Pivotal Obesity Program For MariTide

Novartis Looks To Maintain A Lead In Radiopharmaceuticals With Mariana Takeout

See All
UsernamePublicRestriction

Register

SC063990

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By